Research and Markets: Global Rheumatoid Arthritis Drugs Market 2014-2018

Research and Markets (http://www.researchandmarkets.com/research/fnq4jw/global_rheumatoid) has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering.

RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs.

The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.

The analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Top Drugs

08. Five Forces Analysis

09. Market Segmentation by Category

10. Geographical Segmentation

11. Buying Criteria

12. Rate of Incidence and Prevalence

13. Pipeline Snapshot

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

21. Key Vendor Analysis

22. Other Reports in this Series

Companies Mentioned:

• AbbVie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Janssen Pharmaceuticals Inc.
• Pfizer Inc.
• AB Science SA
• Astellas Pharma Inc.
• AstraZeneca plc
• Biogen Idec Inc.
• Boehringer Ingelheim GmbH
• Celgene Corp.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly & Co.
• GE Healthcare Co.
• Genmab A/S
• GSK plc
• Incyte Corp.
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corp.
• Novartis AG
• Novo Nordisk A/S
• Rigel Pharmaceuticals Inc.
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• UCB SA
• Vertex Pharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/fnq4jw/global_rheumatoid